SLC1A4
Basic information
Region (hg38): 2:64988477-65023865
Links
Phenotypes
GenCC
Source:
- spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome (Supportive), mode of inheritance: AR
- spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome (Strong), mode of inheritance: AR
- spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome (Definitive), mode of inheritance: AR
- complex neurodevelopmental disorder (Limited), mode of inheritance: AD
- spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic tetraplegia, thin corpus callosum, and progressive microcephaly | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 25930971; 26041762; 26138499; 29989513; 31763347 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (10 variants)
- Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome (3 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC1A4 gene is commonly pathogenic or not. These statistics are base on transcript: . Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 181 | 188 | ||||
missense | 90 | 101 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 9 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
Total | 11 | 10 | 91 | 185 | 10 |
Highest pathogenic variant AF is 0.000105129
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC1A4 | protein_coding | protein_coding | ENST00000234256 | 8 | 35389 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0656 | 0.932 | 125718 | 0 | 29 | 125747 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.73 | 219 | 304 | 0.721 | 0.0000165 | 3366 |
Missense in Polyphen | 121 | 166.48 | 0.72681 | 1859 | ||
Synonymous | 0.486 | 128 | 135 | 0.947 | 0.00000812 | 1179 |
Loss of Function | 2.62 | 5 | 16.5 | 0.303 | 7.99e-7 | 200 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000194 | 0.000193 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Transporter for alanine, serine, cysteine, and threonine. Exhibits sodium dependence. {ECO:0000269|PubMed:26041762}.;
- Pathway
- Argininemia;Citrullinemia Type I;Carbamoyl Phosphate Synthetase Deficiency;Argininosuccinic Aciduria;Glucose-Alanine Cycle;Urea Cycle;Glutaminolysis and Cancer;Ornithine Transcarbamylase Deficiency (OTC Deficiency);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Tyrosine metabolism;Amino acid transport across the plasma membrane;Amino acid and oligopeptide SLC transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Histidine metabolism;Methionine and cysteine metabolism;Glycerophospholipid metabolism;Porphyrin metabolism;Glycine, serine, alanine and threonine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.173
Intolerance Scores
- loftool
- 0.519
- rvis_EVS
- -0.11
- rvis_percentile_EVS
- 45.36
Haploinsufficiency Scores
- pHI
- 0.127
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.472
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.618
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc1a4
- Phenotype
Gene ontology
- Biological process
- amino acid transport;glutamine transport;L-alanine transport;L-cystine transport;proline transport;L-serine transport;threonine transport;hydroxyproline transport;synaptic transmission, glutamatergic;proline transmembrane transport;cognition;chloride transmembrane transport
- Cellular component
- centrosome;microtubule organizing center;intermediate filament;plasma membrane;integral component of plasma membrane;cell surface;membrane;integral component of membrane;dendrite;melanosome;neuronal cell body;extracellular exosome
- Molecular function
- chloride channel activity;amino acid transmembrane transporter activity;L-alanine transmembrane transporter activity;L-cystine transmembrane transporter activity;L-glutamine transmembrane transporter activity;L-proline transmembrane transporter activity;L-serine transmembrane transporter activity;L-threonine transmembrane transporter activity;symporter activity;L-hydroxyproline transmembrane transporter activity